1. Children randomized to the MenA group rather than the Vi-TT group were more likely to be diagnosed with typhoid fever. 2. Overall Vi-TT vaccine efficacy was 78.3% with the highest efficacy seen for children aged 2-4 years. Evidence Rating Level: 1 (Excellent) Study Rundown: Typhoid conjugate vaccines in Africa and Asia have shown high
Malawi Launches Nationwide Rollout of Typhoid Vaccine for Children news.europawire.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.europawire.eu Daily Mail and Mail on Sunday newspapers.
In a recent market intelligence study, Data Bridge Market Research extensively examined the Typhoid Vaccine Market. The findings of this research have been presented in a newly published report that boasts an attractive layout, incorporating visually captivating tables, graphs, charts, and figures. By seamlessly int.